Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William R Adam

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Nephrology (Carlton, Vic.)|June 4, 2008
Hypothesis: a simple algorithm to distinguish between hypoaldosteronism and renal aldosterone resistance in patients with persistent hyperkalemiaWilliam R Adam
The Medical Clinics of North America|December 3, 2014
Nonglycemic targets in diabetesDawn DeWitt, David C Dugdale, William R Adam
BMC Cancer|December 10, 2013
Safety and efficacy of vemurafenib in end stage renal failureMahesh Iddawela, Sarah Crook, Leah George, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Nephrology (Carlton, Vic.)|June 4, 2008
Hypothesis: a simple algorithm to distinguish between hypoaldosteronism and renal aldosterone resistance in patients with persistent hyperkalemiaWilliam R Adam
The Medical Clinics of North America|December 3, 2014
Nonglycemic targets in diabetesDawn DeWitt, David C Dugdale, William R Adam
BMC Cancer|December 10, 2013
Safety and efficacy of vemurafenib in end stage renal failureMahesh Iddawela, Sarah Crook, Leah George, et al.
Pageof 1